Patient Access to Innovative New Technologies Act of 2025
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 3
- Latest action
- Jul 16, 2025
What it does
The Patient Access to Innovative New Technologies Act of 2025 would amend Medicare’s New Technology Add-On Payment (NTAP) Program to allow breakthrough medical devices—those designated for expedited development by the FDA and later approved, cleared, or authorized—to receive conditional NTAP payments even if they do not meet the standard approval deadline, as long as they receive FDA authorization before July 1 of the applicable fiscal year. This change aims to reduce delays in Medicare coverage for innovative devices that improve health care quality and outcomes, particularly for beneficiaries receiving hospital inpatient services. The bill applies to breakthrough devices approved,…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.